Exenatide for Myocardial Protection During Reperfusion Study

NCT01938235 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]